Victor Velculescu
机构: Professor of Oncology, Johns Hopkins University School of Medicine
每年引用次数
引用次数
引用: 138,700
H-指数: 128
I10-指数 : 224
出版物: 477
Biological and clinical importance of the p53 tumor suppressor gene.
V E Velculescu , W S El-Deiry
Clinical Chemistry 42 ( 6) 858 -868
159
1996
Implications of micro-RNA profiling for cancer diagnosis.
J M Cummins , V E Velculescu
Oncogene 25 ( 46) 6220 -6227
335
2006
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia
X Zhang , M Reis , R Khoriaty , Y Li
Leukemia 25 ( 12) 1908 -1910
26
2011
1497TiP REACTION – a phase Ib pilot study of nivolumab or nivolumab in combination with relatlimab after targeted radiation in patients with advanced esophagogastric cancer
V.K. Lam , R. Hales , J.L. Feliciano , K.R. Voong
Annals of Oncology 31
2020
521TiP Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer according the trials within cohorts design: The MEDOCC-CrEATE trial
S Schraa , K Van Rooijen , DVD Kruijssen , C Rubio Alarcón
Annals of Oncology 31
2020
Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes.
L. A. Diaz , Y. Jiao , C. Shi , B. H. Edil
Journal of Clinical Oncology 29 10501 -10501
2011
P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1
J Caushi , Z Ji , J Zhang , M El Asmar
Journal of Thoracic Oncology 14 ( 10)
1
2019
MA04.11 Neoantigen Targeting and T Cell Reshaping in Resectable NSCLC Patients Treated with Neoadjuvant PD-1 Blockade
M El Asmar , J Zhang , J Caushi , Z Ji
Journal of Thoracic Oncology 13 ( 10)
2018
MA11.10 Peripheral T Cell Repertoire Evolution in Resectable NSCLC Treated with Neoadjuvant PD-1 Blockade
J Zhang , Z Ji , J Caushi , M El Asmar
Journal of Thoracic Oncology 14 ( 10)
2019
218 Genomic analysis identifies novel drivers and targetable pathways in inflammatory breast cancer patient samples
D.M. Moran , K. Rao , P. Bacon-Trusk , K. Pry
European Journal of Cancer 50 74
2014
STATISTICAL METHODS FOR THE ANALYSIS OF CANCER GENOME SEQUENCING DATA
Giovanni Parmigiani , B. Vogelstein , Simina Boca , K.W. Kinzler
7
2007
Blueprint of the breast and colorectal cancer genomes
V.E. Velculescu
Ejc Supplements 6 ( 9) 123
2008
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
T.R. Cottrell , E.D. Thompson , P.M. Forde , J.E. Stein
Annals of Oncology 29 ( 8) 1853 -1860
260
2018
NSCLC, early stageNeoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
P.M. Forde , K.N. Smith , J.E. Chaft , M. Hellmann
Annals of Oncology 27
13
2016
0 Nature America, Inc. All rights reserv
Colin Stewart ,
Nature 20 1 -1
0 Nature America, Inc. All rights reserv
T Barber , S Jones , KW Kinzler , J Lin
Nature 20 1 -1
High-throughput gene expression analysis using SAGE
Arthur H Bertelsen , Victor E Velculescu
Drug Discovery Today 3 ( 4) 152 -159
41
1998
Analysis of human transcriptomes
Victor E Velculescu , Stephen L Madden , Lin Zhang , Alex E Lash
Nature Genetics 23 ( 4) 387 -388
960
1999
Sodium ion channel mutations in glioblastoma patients correlate with shorter survival
Avadhut D Joshi , D Parsons , Victor E Velculescu , Gregory J Riggins
Molecular Cancer 10 ( 1) 17 -17
41
2011
Characterization of the yeast transcriptome
Victor E Velculescu , Lin Zhang , Wei Zhou , Jacob Vogelstein
Cell 88 ( 2) 243 -251
1,498
2000